3-nitropropionic acid has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camins, A; Crespo-Biel, N; del Valle, J; Duran-Vilaregut, J; Ferrer, I; Pallàs, M; Pelegrí, C; Vilaplana, J | 1 |
| Alli, S; Ashbrook, DG; Cox, R; Dietrich, P; Dragatsis, I; Mulligan, MK; Williams, RW | 1 |
2 other study(ies) available for 3-nitropropionic acid and cyclin d1
| Article | Year |
|---|---|
Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid.
Topics: Animals; Apoptosis; Cell Cycle Proteins; Convulsants; Corpus Striatum; Cyclin D1; Disease Models, Animal; Dyskinesia, Drug-Induced; E2F1 Transcription Factor; Female; G1 Phase; Gene Expression Regulation; Genes, cdc; Humans; Huntington Disease; Male; Nerve Degeneration; Neurons; Neurotoxins; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Up-Regulation | 2008 |
Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration.
Topics: Corpus Striatum; Cyclin D1; Nitro Compounds; Propionates | 2022 |